Xi'an Xice Testing Technology Co., Ltd. (SHE:301306)

Market Cap	5.66B
Revenue (ttm)	356.21M
Net Income (ttm)	-142.24M
Shares Out	84.40M
EPS (ttm)	-1.69
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,955,146
Average Volume	7,896,717
Open	70.94
Previous Close	70.19
Day's Range	68.92 - 73.35
52-Week Range	28.61 - 73.23
Beta	1.11
RSI	63.25
Earnings Date	Aug 28, 2025

About Ligand Pharmaceuticals

Xi'an Xice Testing Technology Co., Ltd. provides testing services in China. The company offers environment and reliability test, such as climate environment test, mechanical environment test, comprehensive stress test, and reliability test, etc.; electromagnetic compatibility test; and testing and screening of electronic components and related technical consulting services. Its services cover aerospace, aviation, weapons, ships, electronics, and civil aircraft industries and fields. The company was founded in 2010 and is based in Xi'an, China.

• Industry: Aerospace & Defense
• Sector: Industrials
• Founded: 2010
• Employees: 1,016
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301306

Financial Performance

In 2024, SHE:301306's revenue was 388.81 million, an increase of 33.57% compared to the previous year's 291.09 million. Losses were -158.27 million, 206.1% more than in 2023.